(Q53318112)

13 May 2018

title

Association between prescription of conventional or atypical antipsychotic drugs and mortality in older persons with Alzheimer's disease. (English)

1 reference

13 May 2018

author

Katie Palmer

2

1 reference

13 May 2018

Antonio Russo

3

1 reference

13 May 2018

Fulvio Adorni

5

1 reference

13 May 2018

Carlo Caltagirone

4

object named as

Carlo Caltagirone

1 reference

13 May 2018

Massimo Musicco

1

1 reference

13 May 2018

Carla Pettenati

6

1 reference

13 May 2018

Luigi Bisanti

7

1 reference

13 May 2018

publication date

6 April 2011

1 reference

13 May 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

13 May 2018

volume

31

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

218-224

1 reference

13 May 2018

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

cites work

1 reference

Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background

21 January 2018

1 reference

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

21 January 2018

1 reference

Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials

21 January 2018

1 reference

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

21 January 2018

1 reference

Exposure to antipsychotics and risk of stroke: self controlled case series study

21 January 2018

1 reference

Risk of death in elderly users of conventional vs. atypical antipsychotic medications

21 January 2018

1 reference

Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.

21 January 2018

1 reference

All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study

21 January 2018

1 reference

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

21 January 2018

1 reference

Antipsychotic drug use and mortality in older adults with dementia

21 January 2018

1 reference

Diagnosis and management of delirium near the end of life

21 January 2018

1 reference

A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease

21 January 2018

1 reference

Survival after Initial Diagnosis of Alzheimer Disease

21 January 2018

1 reference

Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up

21 January 2018

1 reference

Comorbidity measures for use with administrative data

21 January 2018

1 reference

Management of agitation and aggression associated with Alzheimer disease

21 January 2018

1 reference

Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease.

21 January 2018

1 reference

Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000326213

1 reference

13 May 2018

1 reference

13 May 2018